Establishment Labs Holdings Inc. $ESTA is Tyro Capital Management LLC’s Largest Position

Tyro Capital Management LLC lifted its position in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 0.3% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 1,066,721 shares of the company’s stock after buying an additional 2,835 shares during the period. Establishment Labs accounts for approximately 17.9% of Tyro Capital Management LLC’s portfolio, making the stock its largest holding. Tyro Capital Management LLC’s holdings in Establishment Labs were worth $45,560,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. Mudita Advisors LLP lifted its stake in shares of Establishment Labs by 15.6% during the 1st quarter. Mudita Advisors LLP now owns 479,359 shares of the company’s stock worth $19,560,000 after purchasing an additional 64,859 shares during the period. New York State Common Retirement Fund purchased a new position in Establishment Labs during the first quarter worth about $894,000. Milestone Asset Management LLC acquired a new stake in Establishment Labs in the 2nd quarter worth about $523,000. Pier Capital LLC acquired a new stake in Establishment Labs in the 2nd quarter worth about $10,777,000. Finally, Swiss National Bank grew its holdings in Establishment Labs by 1.3% in the 1st quarter. Swiss National Bank now owns 39,000 shares of the company’s stock valued at $1,591,000 after buying an additional 500 shares during the period. Institutional investors and hedge funds own 72.91% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. Mizuho upped their price target on shares of Establishment Labs from $70.00 to $85.00 and gave the stock an “outperform” rating in a research report on Thursday, November 6th. JPMorgan Chase & Co. lifted their target price on Establishment Labs from $45.00 to $71.00 and gave the company an “overweight” rating in a report on Thursday, November 6th. Citigroup reaffirmed a “neutral” rating on shares of Establishment Labs in a research note on Tuesday, October 7th. Canaccord Genuity Group raised their price target on shares of Establishment Labs from $60.00 to $72.00 and gave the company a “buy” rating in a report on Thursday, November 6th. Finally, BTIG Research boosted their price objective on shares of Establishment Labs from $62.00 to $70.00 and gave the stock a “buy” rating in a research note on Wednesday, November 5th. Six equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $66.71.

Establishment Labs Price Performance

ESTA stock opened at $68.45 on Wednesday. The stock’s 50 day moving average is $45.23 and its two-hundred day moving average is $41.10. Establishment Labs Holdings Inc. has a 52-week low of $26.56 and a 52-week high of $69.00. The company has a market capitalization of $1.99 billion, a PE ratio of -24.10 and a beta of 0.98. The company has a quick ratio of 1.67, a current ratio of 3.33 and a debt-to-equity ratio of 15.06.

Establishment Labs (NASDAQ:ESTA) last released its quarterly earnings results on Wednesday, November 5th. The company reported ($0.38) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.54) by $0.16. Establishment Labs had a negative net margin of 43.45% and a negative return on equity of 235.45%. The business had revenue of $53.78 million during the quarter, compared to the consensus estimate of $52.28 million. During the same quarter last year, the company earned ($0.59) earnings per share. The business’s quarterly revenue was up 33.8% compared to the same quarter last year. Establishment Labs has set its FY 2025 guidance at EPS. Analysts predict that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current fiscal year.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.